E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.39 EUR 1.8% Market Closed
Market Cap: 324.1m EUR

EV/EBIT
Enterprise Value to EBIT

-36.9
Current
40.1
Median
16.3
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-36.9
=
Enterprise Value
313.5m EUR
/
EBIT
-8.5m EUR
Market Cap EV/EBIT
FR
Euroapi SAS
PAR:EAPI
322.8m EUR -36.9
US
Eli Lilly and Co
NYSE:LLY
729.6B USD 38.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
372.9B USD 16.4
DK
Novo Nordisk A/S
CSE:NOVO B
2.2T DKK 16.5
CH
Roche Holding AG
SIX:ROG
213.3B CHF 11.3
CH
Novartis AG
SIX:NOVN
190.2B CHF 14.2
UK
AstraZeneca PLC
LSE:AZN
167.2B GBP 197.7
US
Merck & Co Inc
NYSE:MRK
198.7B USD 10.3
IE
Endo International PLC
LSE:0Y5F
163.5B USD 655.3
US
Pfizer Inc
NYSE:PFE
132.7B USD 10.3
EBIT Growth EV/EBIT to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBIT: 1 867.3
Negative Multiple: -36.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.6
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.4
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
16.5
14%
1.2
CH
Roche Holding AG
SIX:ROG
11.3
6%
1.9
CH
Novartis AG
SIX:NOVN
14.2
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.7
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.3
11%
0.9
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
10%
1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-6.3
2-Years Forward
EV/EBIT
-12.6
3-Years Forward
EV/EBIT
16